BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 17053269)

  • 1. Brain natriuretic peptide, clinical reasoning, and congestive heart failure.
    Ammar H; Malani AK; Gupta C; Dobyan DC
    Am J Crit Care; 2006 Nov; 15(6):614-6. PubMed ID: 17053269
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute dyspnea: what is the diagnostic role of B-type natriuretic peptide?].
    Sarasin FP
    Rev Med Suisse; 2005 Aug; 1(29):1888-91. PubMed ID: 16152876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incremental benefit of a shortness-of-breath biomarker panel in emergency department patients with dyspnea.
    Singer AJ; Thode HC; Green GB; Birkhahn R; Shapiro NI; Cairns C; Baumann BM; Aghababian R; Char D; Hollander JE
    Acad Emerg Med; 2009 Jun; 16(6):488-94. PubMed ID: 19388909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-type natriuretic peptides for the diagnosis of congestive heart failure in dyspneic oldest-old patients.
    Chenevier-Gobeaux C; Delerme S; Allo JC; Arthaud M; Claessens YE; Ekindjian OG; Riou B; Ray P
    Clin Biochem; 2008 Sep; 41(13):1049-54. PubMed ID: 18573245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of heart failure.
    Chang AM; Maisel AS; Hollander JE
    Heart Fail Clin; 2009 Jan; 5(1):25-35, vi. PubMed ID: 19026383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of acute dyspnea. Anamnesis and clinical exam are often revealing].
    Bischoff A
    MMW Fortschr Med; 2010 May; 152(19):25, 27. PubMed ID: 20556998
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department.
    Ray P; Delerme S; Jourdain P; Chenevier-Gobeaux C
    QJM; 2008 Nov; 101(11):831-43. PubMed ID: 18664534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical value of rapid assay for plasma B-type natriuretic peptide in differentiating congestive heart failure from pulmonary causes of dyspnoea.
    Zhao SQ; Hu YM; Li Q; Liu XR; Wang M; Zhang WY; Wu T; Nie XL; Zhao N; Wang LR
    Int J Clin Pract; 2008 Feb; 62(2):214-20. PubMed ID: 18081799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The circulating NTproBNP level, a new biomarker for the diagnosis of heart failure in patients with acute shortness of breath].
    Bayés-Genís A
    Rev Esp Cardiol; 2005 Oct; 58(10):1142-4. PubMed ID: 16238980
    [No Abstract]   [Full Text] [Related]  

  • 10. B-type natriuretic peptide - a biomarker for all seasons?
    Mark DB; Felker GM
    N Engl J Med; 2004 Feb; 350(7):718-20. PubMed ID: 14960748
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating natriuretic peptide levels in acute heart failure.
    Maisel A
    Rev Cardiovasc Med; 2007; 8 Suppl 5():S13-21. PubMed ID: 18192949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel biomarkers for the diagnosis of acute destabilised heart failure in patients with shortness of breath.
    Achanta SS
    Heart; 2009 Oct; 95(19):1626-7; author reply 1627. PubMed ID: 19752207
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure.
    Omland T
    Crit Care Med; 2008 Jan; 36(1 Suppl):S17-27. PubMed ID: 18158473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.
    van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C
    Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-type natriuretic peptide in the evaluation of acute dyspnea.
    Martinez-Selles M
    N Engl J Med; 2004 Jun; 350(23):2416-7; author reply 2416-7. PubMed ID: 15175447
    [No Abstract]   [Full Text] [Related]  

  • 16. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
    J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FPIN's clinical inquiries: brain natriuretic peptide for ruling out heart failure.
    Cullan A; Grover M; Hitchcock K
    Am Fam Physician; 2011 Jun; 83(11):1333-4. PubMed ID: 21661716
    [No Abstract]   [Full Text] [Related]  

  • 18. Brain natriuretic peptide in the contemporary management of congestive heart failure.
    Wasywich CA; Whalley GA; Doughty RN
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):71-84. PubMed ID: 15723576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Getting the right message: avoiding overly optimistic interpretations of the scientific literature.
    Schriger DL
    Ann Emerg Med; 2006 Jul; 48(1):75-6. PubMed ID: 16781922
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevations of B-type natriuretic peptide in pulmonary embolism: a case series.
    Bilkovski RN; Kulstad EB
    J Emerg Med; 2003 Nov; 25(4):415-20. PubMed ID: 14654183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.